231 related articles for article (PubMed ID: 26188095)
1. Targeting ceramide metabolic pathway induces apoptosis in human breast cancer cell lines.
Vethakanraj HS; Babu TA; Sudarsanan GB; Duraisamy PK; Ashok Kumar S
Biochem Biophys Res Commun; 2015 Aug; 464(3):833-9. PubMed ID: 26188095
[TBL] [Abstract][Full Text] [Related]
2. Anticancer effect of acid ceramidase inhibitor ceranib-2 in human breast cancer cell lines MCF-7, MDA MB-231 by the activation of SAPK/JNK, p38 MAPK apoptotic pathways, inhibition of the Akt pathway, downregulation of ERα.
Vethakanraj HS; Sesurajan BP; Padmanaban VP; Jayaprakasam M; Murali S; Sekar AK
Anticancer Drugs; 2018 Jan; 29(1):50-60. PubMed ID: 29023248
[TBL] [Abstract][Full Text] [Related]
3. C6-ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth.
Flowers M; Fabriás G; Delgado A; Casas J; Abad JL; Cabot MC
Breast Cancer Res Treat; 2012 Jun; 133(2):447-58. PubMed ID: 21935601
[TBL] [Abstract][Full Text] [Related]
4. Novel off-target effect of tamoxifen--inhibition of acid ceramidase activity in cancer cells.
Morad SA; Levin JC; Tan SF; Fox TE; Feith DJ; Cabot MC
Biochim Biophys Acta; 2013 Dec; 1831(12):1657-64. PubMed ID: 23939396
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis in prostate cancer cells by the novel ceramidase inhibitor ceranib-2.
Kus G; Kabadere S; Uyar R; Kutlu HM
In Vitro Cell Dev Biol Anim; 2015 Nov; 51(10):1056-63. PubMed ID: 26170224
[TBL] [Abstract][Full Text] [Related]
6. Effects of ceranib-2 on cell survival and TNF-alpha in colon cancer cell line.
Baspinar M; Ozyurt R; Kus G; Kutlay O; Ozkurt M; Erkasap N; Kabadere S; Yasar NF; Erkasap S
Bratisl Lek Listy; 2017; 118(7):391-393. PubMed ID: 28766347
[TBL] [Abstract][Full Text] [Related]
7. Acid ceramidase is upregulated in AML and represents a novel therapeutic target.
Tan SF; Liu X; Fox TE; Barth BM; Sharma A; Turner SD; Awwad A; Dewey A; Doi K; Spitzer B; Shah MV; Morad SA; Desai D; Amin S; Zhu J; Liao J; Yun J; Kester M; Claxton DF; Wang HG; Cabot MC; Schuchman EH; Levine RL; Feith DJ; Loughran TP
Oncotarget; 2016 Dec; 7(50):83208-83222. PubMed ID: 27825124
[TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway.
Elumalai P; Gunadharini DN; Senthilkumar K; Banudevi S; Arunkumar R; Benson CS; Sharmila G; Arunakaran J
Toxicol Lett; 2012 Nov; 215(2):131-42. PubMed ID: 23089555
[TBL] [Abstract][Full Text] [Related]
9. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
10. Targeting acid ceramidase sensitises head and neck cancer to cisplatin.
Roh JL; Park JY; Kim EH; Jang HJ
Eur J Cancer; 2016 Jan; 52():163-72. PubMed ID: 26687835
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of ceramidase inhibition on human renal cell carcinoma: a cell culture study.
Palit F; Vejselova Sezer C; Kutlu HM
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(5 Suppl):121-129. PubMed ID: 37869957
[TBL] [Abstract][Full Text] [Related]
12. Cellular effect of styrene substituted biscoumarin caused cellular apoptosis and cell cycle arrest in human breast cancer cells.
Perumalsamy H; Sankarapandian K; Kandaswamy N; Balusamy SR; Periyathambi D; Raveendiran N
Int J Biochem Cell Biol; 2017 Nov; 92():104-114. PubMed ID: 28958615
[TBL] [Abstract][Full Text] [Related]
13. Examining impacts of ceranib-2 on the proliferation, morphology and ultrastructure of human breast cancer cells.
Vejselova D; Kutlu HM; Kuş G
Cytotechnology; 2016 Dec; 68(6):2721-2728. PubMed ID: 27380965
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic effect of noscapine in breast cancer cell lines.
Quisbert-Valenzuela EO; Calaf GM
Int J Oncol; 2016 Jun; 48(6):2666-74. PubMed ID: 27081867
[TBL] [Abstract][Full Text] [Related]
15. Coenzyme Q0 induces apoptosis and modulates the cell cycle in estrogen receptor negative breast cancer cells.
Somers-Edgar TJ; Rosengren RJ
Anticancer Drugs; 2009 Jan; 20(1):33-40. PubMed ID: 18830129
[TBL] [Abstract][Full Text] [Related]
16. Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen.
Furlong SJ; Mader JS; Hoskin DW
Oncol Rep; 2006 May; 15(5):1385-90. PubMed ID: 16596215
[TBL] [Abstract][Full Text] [Related]
17. Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells.
Choi YH; Yoo YH
Oncol Rep; 2012 Dec; 28(6):2163-9. PubMed ID: 23023313
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative and apoptosis-inducing activity of nobiletin against three subtypes of human breast cancer cell lines.
Chen C; Ono M; Takeshima M; Nakano S
Anticancer Res; 2014 Apr; 34(4):1785-92. PubMed ID: 24692711
[TBL] [Abstract][Full Text] [Related]
19. Modulation of cell cycles and apoptosis by apicidin in estrogen receptor (ER)-positive and-negative human breast cancer cells.
Im JY; Park H; Kang KW; Choi WS; Kim HS
Chem Biol Interact; 2008 Apr; 172(3):235-44. PubMed ID: 18313654
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications.
Morad SA; Cabot MC
Biochim Biophys Acta; 2015 Sep; 1851(9):1134-45. PubMed ID: 25964209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
